Mode
Text Size
Log in / Sign up

Haemorrhage pattern predicts complications in angiogram-negative subarachnoid haemorrhage patientsBlood pattern predicts risk for hidden brain vessel issues in patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider haemorrhage pattern to guide surveillance in angiogram-negative subarachnoid haemorrhage.

This systematic review and meta-analysis examined the clinical course of 5921 patients with angiogram-negative subarachnoid haemorrhage. The analysis focused on how the haemorrhage pattern, categorized as perimesencephalic, non-perimesencephalic, diffuse, or convexity, influences patient outcomes. The review aimed to determine if these patterns are associated with distinct complication profiles that could guide clinical surveillance. The study population consisted of patients who underwent angiography to rule out aneurysms but remained negative for a definitive vascular source. The setting encompassed various clinical environments where these patients were managed over a follow-up period of 3 to 6 months.

The primary intervention of interest was the haemorrhage pattern itself, which served as a stratification variable rather than a therapeutic agent. The comparator was the presence of other haemorrhage patterns within the same cohort. The study did not test a specific drug or device but rather utilized the radiological classification of the bleed to predict risk. This approach allows clinicians to tailor monitoring intensity based on the initial angiogram-negative diagnosis.

Primary outcome assessment focused on favourable functional outcome. The meta-analysis reported that 95% to 97% of patients achieved a favourable functional outcome. The specific breakdown by haemorrhage pattern was not detailed for this primary metric in the provided data, but the overall high rate suggests a generally benign course for this population. Secondary outcomes included rebleeding, clinical vasospasm, acute hydrocephalus requiring external ventricular drainage, and delayed vascular lesion detection.

Rebleeding rates varied significantly by haemorrhage pattern. The rate was 1% for perimesencephalic haemorrhage, 2% for non-perimesencephalic haemorrhage, and 3% for diffuse haemorrhage. Clinical vasospasm incidence was 3% in perimesencephalic cases, 11% in non-perimesencephalic cases, and 13% in diffuse cases. Acute hydrocephalus requiring external ventricular drainage occurred in 7% of perimesencephalic patients, 29% of non-perimesencephalic patients, and 44% of diffuse haemorrhage patients. These differences highlight the prognostic value of the haemorrhage pattern classification.

Delayed vascular lesion detection was another critical finding. A total of 82 vascular lesions were identified during the follow-up period. No lesions were detected within 7 days of the ictus. All identified lesions were found at or beyond 7 days after the initial event. This temporal pattern suggests that early negative imaging does not rule out delayed vascular pathology, particularly in non-perimesencephalic and diffuse patterns.

Safety and tolerability were assessed through the incidence of adverse events. The main adverse events observed were rebleeding, clinical vasospasm, and acute hydrocephalus. The rates of these events were directly linked to the haemorrhage pattern. No specific serious adverse events or discontinuation rates were reported beyond the complication profiles. The study notes that repeat imaging was selectively performed and timing varied across the included studies, which introduces potential heterogeneity.

A key methodological limitation is the selective nature of repeat imaging and the variation in timing across the included studies. This variability may affect the comparability of rebleeding and vasospasm rates. The study does not provide p-values or confidence intervals for the primary outcome, and absolute numbers for some metrics were not fully detailed. Prospective studies are required to define optimal imaging intervals and to confirm these associations with greater certainty.

The clinical implication is that haemorrhage pattern may assist in individualising surveillance strategies. Clinicians can use the pattern to anticipate risks such as hydrocephalus or vasospasm. For instance, diffuse haemorrhage carries a higher risk of hydrocephalus requiring drainage compared to perimesencephalic haemorrhage. However, the evidence is observational, and causality cannot be definitively established. Questions remain regarding the optimal timing for repeat imaging in each pattern to balance detection of delayed lesions against resource utilization.

In conclusion, this meta-analysis provides evidence that haemorrhage pattern is associated with distinct complication profiles in angiogram-negative subarachnoid haemorrhage. The high rate of favourable functional outcomes is encouraging, but the risk of rebleeding and hydrocephalus varies by pattern. The identification of 82 delayed vascular lesions underscores the importance of extended surveillance. Future research must address the limitations of selective imaging and establish standardized protocols for follow-up.

Imagine waking up from surgery with a headache that feels different from the one that started it. You might feel fine most of the time, but a small worry lingers in the back of your mind. Doctors often call this situation angiogram-negative subarachnoid haemorrhage.

This condition happens when blood leaks into the space around the brain but standard scans do not show a clear source. About fifteen percent of all spontaneous brain bleeds fall into this category. Patients often wonder if they truly need more tests or if they can just wait it out.

The answer depends heavily on exactly where the blood settles in the brain. Different patterns of bleeding carry different risks for future problems. Understanding these patterns helps medical teams make smarter choices about patient care.

But here is the twist. Many doctors used to scan everyone repeatedly without a clear plan. This new research changes that approach by linking blood patterns to specific risks.

The Shape Of The Bleed Matters

Think of the blood as paint spilled on a canvas. Where the paint lands tells you a lot about the damage. Some blood spreads around the brainstem, while other blood spreads over the top of the brain.

These locations matter because they affect how the brain heals. The study looked at four main patterns of bleeding. Each one had its own unique set of complications and recovery rates.

The researchers found that most patients did very well. Ninety-five to ninety-seven percent of people had a good recovery within three to six months. This is excellent news for families worried about long-term disability.

However, not every complication was rare. Some issues appeared more often in certain blood patterns. Knowing which pattern a patient has helps doctors predict these problems before they happen.

Hidden Risks And Timing

One major risk is the blood vessels spasming or tightening up. This can reduce blood flow to healthy brain tissue. The study showed that spasms happened in three percent of one group but jumped to thirteen percent in another.

Another risk is fluid buildup in the brain. This condition called hydrocephalus required drainage in seven percent of one group. That number rose to forty-four percent in a different group. These numbers show why the location of the bleed is so important.

Doctors also looked for hidden vessel issues that might cause a second bleed. They found very few of these problems in the first week after the initial bleed. All the hidden lesions were found later, usually at seven days or more.

This does not mean patients should skip their follow-up visits.

The timing of the second scan matters a lot. Scanning too early often misses the hidden problems. Waiting a bit longer allows the body to reveal any delayed issues. This finding could save patients from unnecessary radiation and contrast dye exposure.

The team reviewed sixty-seven different studies. Together these studies included nearly six thousand patients. They used advanced math to combine the results from all these sources. This method gives a clearer picture than looking at one small study alone.

The results were consistent across many different hospitals and countries. The pattern of the blood was the strongest predictor of complications. This is a big deal because it gives doctors a simple tool to use.

Instead of guessing, doctors can now look at the scan and see where the blood is. If the blood is in a high-risk area, they know to watch closely. If it is in a low-risk area, they might wait longer before the next scan.

Real World Impact For Patients

What does this mean for you or your loved ones? It means your doctor can explain your specific risk. You will not get a generic answer anymore. Your care plan will be based on the actual shape of your bleed.

This approach reduces anxiety because the path forward is clearer. You can ask your doctor about the specific risks for your pattern. You can also understand why a scan is scheduled for a certain time.

It is important to talk to your doctor about your specific situation. They know your full history and can apply these findings to your case. Do not stop taking prescribed medications or skip appointments based on internet articles.

The Limits Of The Data

Every study has some limits. This review included many different studies, which is good. But the timing of scans varied a lot between them. Some doctors scanned patients early while others waited. This makes it hard to set a perfect rule for everyone.

Also, the research mostly looked at adults. We do not know much about children or older adults with other health issues. More research is needed to fill these gaps.

What Happens Next

Doctors will use this new information to update their guidelines. They will likely create clearer rules for when to scan again. This will help standardize care across different hospitals.

Future studies will focus on the best timing for scans. They will also look at how to treat the high-risk groups better. The goal is to keep patients safe while avoiding unnecessary tests.

This research brings us closer to personalized medicine. Your treatment will fit your specific needs rather than a one-size-fits-all approach. That is a huge step forward for brain injury care.

Study Details

Study typeMeta analysis
Sample sizen = 5,921
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BACKGROUND: Angiogram-negative subarachnoid haemorrhage accounts for approximately 15% of spontaneous subarachnoid haemorrhage, yet surveillance practices and the role of repeat vascular imaging remain inconsistent. The extent to which haemorrhage pattern predicts clinical complications and delayed vascular lesion detection is uncertain. METHODS: We conducted a systematic review and meta-analysis in accordance with PRISMA guidelines. Studies reporting clinical outcomes in angiogram-negative subarachnoid haemorrhage were included. Outcomes were pooled using random-effects generalised linear mixed models and stratified by haemorrhage pattern, including perimesencephalic, non-perimesencephalic, diffuse, and convexity haemorrhage. RESULTS: Sixty-seven studies comprising 5,921 patients were included. Favourable functional outcome at 3-6 months occurred in 95-97% of patients across all haemorrhage patterns. Rebleeding was uncommon, occurring in 1% of perimesencephalic, 2% of non-perimesencephalic, and 3% of diffuse haemorrhage. Clinical vasospasm occurred in 3%, 11%, and 13%, respectively, while acute hydrocephalus requiring external ventricular drainage occurred in 7%, 29%, and 44%. Among studies reporting repeat vascular imaging, 82 vascular lesions were identified, predominantly in non-perimesencephalic haemorrhage. No lesions were detected on imaging performed within 7 days of ictus; all reported lesions were identified at or beyond 7 days, although repeat imaging was selectively performed and timing varied across studies. CONCLUSION: Angiogram-negative subarachnoid haemorrhage is clinically heterogeneous. Haemorrhage pattern is associated with distinct complication profiles and differential observed yields of delayed vascular lesion detection, and may assist in individualising surveillance strategies. Prospective studies are required to define optimal imaging intervals.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.